Population Council

Knowledge Commons

2018

Assessing the feasibility and acceptability of community health
extension workers to treat hypertension associated with
pregnancy: An analysis of post-intervention findings
Salisu Mohammed Ishaku
Population Council

Follow this and additional works at: https://knowledgecommons.popcouncil.org/departments_sbsr-rh
Part of the Civic and Community Engagement Commons, Demography, Population, and Ecology
Commons, Family, Life Course, and Society Commons, and the International Public Health Commons

How does access to this work benefit you? Let us know!
Recommended Citation
Ishaku, Salisu Mohammed. 2018. "Assessing the feasibility and acceptability of community health
extension workers to treat hypertension associated with pregnancy: An analysis of post-intervention
findings," Ending Eclampsia Research Brief. Abuja: Population Council.

This Brief is brought to you for free and open access by the Population Council.

Research Brief

NIGERIA

AUGUST 2018

Assessing the feasibility and acceptability of
community health extension workers to treat
hypertension associated with pregnancy: An
analysis of post-intervention findings

The Population Council conducts research and delivers solutions that
improve lives around the world. Big ideas supported by evidence:
It’s our model for global change. popcouncil.org
Made possible by the generous support of the
American people through the United States Agency
for International Development (USAID).

© 2018 The Population Council, Inc.

BACKGROUND
In Nigeria, hypertensive disorders of pregnancy (HDPs) – mainly pre-eclampsia
and eclampsia (PE/E) – are the most common causes of death in pregnant
women, accounting for 23 percent of maternal deaths in tertiary health facilities.
Uncon¬trolled hypertension puts women at risk of cerebrovascular accident, a
common cause of death from PE/E. Averting deaths from PE/E requires early
detection, timely delivery of the baby, effective use of antihypertensive drugs
to control the associated hypertension, and administration of magnesium
sulphate (MgSO4) to prevent and treat convulsions.

•

Pre-eclampsia is a condition in
pregnant women marked by an
increase in blood pressure and
protein in urine after 20 weeks
gestation.

•

Providing high quality antenatal
care improves the prevention and
early detection of pre-eclampsia
and can prevent its progression to
eclampsia.

•

Eclampsia is a life-threatening
condition characterized by
convulsions in women with PE.

RESEARCH AIM

•

This study tested the feasibility of tasking CHEWs with detecting and
managing hypertension, and prescribing an oral antihypertensive drug –
alpha methyldopa (aldomet) – at primary health care (PHC) facilities as
part of a package of care for women with PE/E. This evaluation measured
improve¬ments in knowledge retention and increases in early detection,
prevention, and management of PE/E.

Women in developing countries
are 300 times more likely to die
from eclampsia than women in
developed countries.

•

Prescribing low-dose aspirin
and calcium to at-risk women
can prevent pre-eclampsia and
eclampsia.

INTERVENTION

•

Pre-eclampsia and eclampsia can
be managed by administering
anti-hypertensive drugs and
magnesium sulphate (MgSO4).

•

MgSO4 is the safest and most
effective treatment for severe
PE/E, and is one of 13 UN LifeSaving Commodities for Women
and Children.

•

PE/E and other hypertensive
disorders in pregnancy increase
the risk of pre-term births, which
can lead to low birth weight,
anemia, and stunting.

•

Improved prevention, increased
detection, and effective treatment
of PE/E can prevent unnecessary
maternal and newborn deaths.

Community Health Extension Workers (CHEWs) are authorized to administer
the loading of MgSO4 prior to referring a pregnant woman with PE/E to a
secondary or tertiary health facility. Nigeria’s task shifting policy is unclear
on whether CHEWs – often the first points of contact for pregnant women
– are permitted to administer antihypertensive drugs to pregnant women.
There is a need, therefore, to determine whether CHEWs can safely administer
antihypertensive drugs for HDPs.

In Ebonyi State, 43 CHEWs in 20 intervention PHCs received training (theory)
and mentoring (skills) on accurate measurement of blood pressure (BP) in
pregnant women and categorization as normal, mild, moderate, or severe
hypertension, as well as how to manage hypertension using oral alpha
methyldopa.
CHEWs in the intervention facilities prescribed and dispensed alpha
methyldopa to women with moderate and se-vere hypertension. If the drug was
not available at the facility, women and their families may have had to obtain
the drug at outside, local pharmacies. CHEWs then asked women to return
to the PHC for refills and BP measurement every month during pregnancy.
If hypertension was not controlled, women were referred to a hospital. In an
impending case of severe PE/E, the woman received the loading dose of
MgSO4 according to national policy and was referred to a secondary facility for
further management.
Twenty-nine CHEWs in 20 comparison facilities did not prescribe alpha
methyldopa, but instead were expected to refer pregnant women with moderate
or high BP to referral hospitals. Any available physicians in comparison
facilities could dispense and prescribe antihypertensive drugs, based on their
clinical judgment to best address the woman’s condition.
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Pre-eclampsia/ Eclampsia
(PE/E) IN BRIEF

The Ending Eclampsia project seeks to expand access
to proven,underutilized interventions and commodities
for the prevention, early detection, and treatment of
pre-eclampsia and eclampsia and strengthen global
partnerships.

FINDINGS
CHEWs’ Knowledge Retention
Trained CHEWs working at intervention PHCs can
correctly identify, differentiate, and manage normal,
mild, moderate, and severe hypertension. At baseline,
only 4% of intervention providers could correctly
identify hypertension as normal, mild, moderate, or
severe, but at endline 67% could correctly differentiate.
Overall, intervention providers were 60% more likely to
correctly identify hypertension than the comparison
group (p<.001). Following training, 75% providers
could correctly describe how to manage hypertension,
compared to only 40% at baseline (p<0.001); comparison
group providers saw a decrease in knowledge retention of
hypertension management from 38% to 16% (p<0.001).
There was 55% improvement in knowledge of proper
timing for administration of a MgSO4 loading dose among
trained providers, whereas comparison provider MgSO4
knowledge at endline improved by only 14% (p=0.021).
Figure 1 below describes changes in CHEW’s knowledge
of HDPs pre- and post-intervention.
CHEWs’ Knowledge of Treating Hypertension
Ninety-two percent of CHEWs in intervention facilities
identified alpha methyldopa as a drug used to control
BP at endline, compared to 14% at baseline. Overall,
CHEWs in the intervention group were 36% more likely
to name alpha methyldopa as a drug used to control
blood pressure than CHEWs in the comparison group
(p=.019). In the intervention and control groups,
CHEWs were more likely to prescribe alpha methyldopa
over other antihypertensive drugs (60% and 50%
of providers, respectively). Interestingly, theoretical
knowledge of antihypertensives and actual practice
do not always align and require sustained oversight
and mentorship. For example, though almost no
CHEWs in either the intervention or comparison groups
spontaneously named Labetalol as a drug that controls
blood pressure, in practice, it was the second most-

prescribed antihypertensive drug after alpha methyldopa
among CHEWs in the intervention group at endline
(34.3% of providers named it as the most prescribed
antihypertensive at their facility).
CHEWs’ Ability to Diagnose & Treat Hypertension
Following training, only one patient seen by the intervention
providers was incorrectly diagnosed, while one woman
was correctly diagnosed with PE, 15 with severe PE, and
23 with another HDP. Comparison providers incorrectly
diagnosed nine women, but correctly diagnosed one
woman with PE and four women with other HDPs.
Among women with moderate-to-severe hypertension
who required antihypertensive drugs upon diagnosis,
89% of women in the intervention PHCs received
treatment, compared to only 20% in the comparison
PHCs. Furthermore, 50% of women with severe PE in
the intervention PHCs received a loading dose of MgSO4
at diagnosis, but no women in the comparison PHCs
received the loading dose. Most PHCs in intervention and
comparison groups procure antihypertensive drugs from
facility arrangements within the open market (92% and
57%, respectively). CHEWs from both groups reported
that procurement cost is the greatest barrier to stocking
antihypertensive drugs.
Between July 2016 and December 2017, 54 pregnant
women from Ebonyi State who presented with high BP
were monitored and followed up until after delivery. See
Table 1 for client details. Gestational age at point of first
contact with PHCs shows that no women in our sample
sought ANC prior to 12 weeks of pregnancy and many
waited until close to their third trimester, suggesting
normalized delays maternal care-seeking.
Maternal & Fetal Health Outcomes

Throughout the duration of this study, there were five
maternal deaths – one in the intervention group and
four in the comparison group. Thirteen fetal deaths
occurred, four in the intervention group and nine in the
Figure 1: CHEWs’ pre- and post-intervention knowledge of hypertensive disorders in pregnancy
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Table 1: Characteristics of pregnant women at first and follow up ANC visits
Women’s Characteristics
Age

Education

Intervention PHCs, n=40 (%)

Comparison PHCs, n=14 (%)

15-24

9 (22.5)

5 (35.7)

14 (25.9)

25-34

19 (47.5)

4 (28.6)

23 (42.6)

>35

12 (30)

5 (35.7)

17 (31.5)

No formal education

7 (17.5)

1 (7.7)

8 (15.1)

Primary

11 (27.5)

4 (30.8)

15 (28.3)

Secondary

19 (47.5)

8 (61.6)

27 (50.9)

BP at ANC booking

Proteinuria at ANC booking

Gestation at ANC booking

Gestation at HDP diagnosis

First degree

3 (7.5)

0

3 (5.6)

<140/90 mmhg

14 (35)

10 (71.4)

24 (44.4)

>140/90 mmhg

21 (52.5)

2 (14.3)

23 (42.6)

Unrecorded

5 (12.5)

2 (14.3)

7 (13)

0

0

0

+1
+2

2 (10)

0

4 (7.4)

>+3

5 (12.5)

0

5 (9.3)

Nil/ trace

31 (77.5)

14 (100)

45 (83.3)

<12 weeks

0

0

0

12-20 weeks

13 (32.5)

5 (35.7)

18 (33.3)

21-30 weeks

11 (27.5)

4 (28.6)

15 (28)

31-40 weeks

10 (25)

2 (14.3)

12 (19.7)

0

0

0

12-20 weeks

6 (15)

3 (21.4)

9 (16.7)

21-30 weeks

15 (37.5)

4 (28.5)

19 (35.2)

31-40 weeks

15 (37.5)

7 (50)

22 (40.8)

<12 weeks

comparison group. All maternal deaths occurred among
women who did not receive MgSO4. To better understand
barriers that lead to these deaths, further analysis of the
timing of severe PE/E diagnosis and reasons for delay in
administering the loading dose is needed.

DISCUSSION
Findings from this study to task-shift PE/E detection
and management to CHEWs are encouraging. Overall,
PHC providers are able to distinguish mild, moderate,
and severe hypertension in pregnant women and
diagnose PE/E at PHCs. Improvements among CHEWs
who received intensive training, as well as differences
between intervention and comparison CHEWs, indicate
that HDPs and PE/E can be detected and managed
at the PHC level. Challenges continue when ensuring
women have access to care early in their pregnancies. As
mentioned, appropriate PE/E management requires early
detection, but the majority of women came to their first
ANC appointment (booking appointment) once high BP
had occurred and they felt unwell.
A national task-shifting policy exists in Nigeria, and these
findings are important contributions to implementing the

national policy at the local level. Training and mentoring
CHEWs to detect and manage PE/E at the local level
will improve access to life-saving care for women, their
families, and their communities, and will contribute to
stronger health systems and improved maternal health
outcomes in Nigeria.

RECOMMENDATIONS
•

Sustain CHEW training, mentoring, and oversight, as
needed for the detection and management of HDPs;

•

Streamline state procurement for supplies and
commodities, and enhance linkages to central
distribution system of antihypertensive drugs and
MgSO4;

•

Amend national task-shifting policy to explicitly
include antihypertensive drug administration at the
PHC level;

•

Scale up task-shifting for antihypertensive drug use
at PHC level across Nigeria; and

•

Conduct further analysis to understand women’s
maternal health-seeking behavior.
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